Assignee
OSPEDALE SAN RAFFAELE SRL
IT·27 granted patents·53 pending applications·26 citations·filing 2013–2025
Top patents by PatentIndex Score
80 records- 0189US11020453B2Inhibitor of IGFBP3/TMEM219 axis and diabetesOSPEDALE SAN RAFFAELE SRL·Filed 2018·Granted Jun 1, 2021·4 cites·22 claims
- 0286US10912824B2Vector productionOSPEDALE SAN RAFFAELE SRL·Filed 2015·Granted Feb 9, 2021·4 cites·24 claims
- 0386US10682391B2Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseasesOSPEDALE SAN RAFFAELE SRL·Filed 2016·Granted Jun 16, 2020·4 cites·10 claims
- 0482US2024218370A1Gene VectorOSPEDALE SAN RAFFAELE SRL·Filed 2023·Application pending·0 cites
- 0580US11407996B2Gene vectorOSPEDALE SAN RAFFAELE SRL·Filed 2019·Granted Aug 9, 2022·1 cites·17 claims
- 0680US11395835B2Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytesOSPEDALE SAN RAFFAELE SRL·Filed 2018·Granted Jul 26, 2022·1 cites·19 claims
- 0779US10626153B2HMGB1 variants and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2013·Granted Apr 21, 2020·7 cites·9 claims
- 0876US12485187B2Method for improving retroviral transduction and gene editing in hematopoietic stem cells using clyclosporin H and UM171OSPEDALE SAN RAFFAELE SRL·Filed 2024·Granted Dec 2, 2025·0 cites·22 claims
- 0976US9974808B2Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytesOSPEDALE SAN RAFFAELE SRL·Filed 2015·Granted May 22, 2018·2 cites·9 claims
- 1075US10391201B2Gene therapyOSPEDALE SAN RAFFAELE SRL·Filed 2015·Granted Aug 27, 2019·3 cites·15 claims
- 1167US11957747B2Vector productionOSPEDALE SAN RAFFAELE SRL·Filed 2021·Granted Apr 16, 2024·0 cites·14 claims
- 1267US2021169973A1Inhibitor of IGFBP3/TMEM219 Axis and DiabetesOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 1366US2024408145A1Gene TherapyOSPEDALE SAN RAFFAELE SRL·Filed 2022·Application pending·0 cites
- 1465US2025281540A1Methods for Haematopoietic Stem Cell TransplantationOSPEDALE SAN RAFFAELE SRL·Filed 2023·Application pending·0 cites
- 1565US2025325705A1Gene therapyOSPEDALE SAN RAFFAELE SRL·Filed 2024·Application pending·0 cites
- 1665US2025114386A1Combination of a glycosylation inhibitor with one car cell therapy for treating cancerOSPEDALE SAN RAFFAELE SRL·Filed 2024·Application pending·0 cites
- 1763US11753643B2Gene vectorOSPEDALE SAN RAFFAELE SRL·Filed 2018·Granted Sep 12, 2023·0 cites·16 claims
- 1862US2025236870A1Permanent epigenetic gene silencingOSPEDALE SAN RAFFAELE SRL·Filed 2024·Application pending·0 cites
- 1961US2025281645A1Lentiviral VectorOSPEDALE SAN RAFFAELE SRL·Filed 2023·Application pending·0 cites
- 2061US2025376696A1Virus vector productionOSPEDALE SAN RAFFAELE SRL·Filed 2025·Application pending·0 cites
- 2159US12221476B2Antibodies and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2019·Granted Feb 11, 2025·0 cites·22 claims
- 2259US2025269066A1Gene therapyOSPEDALE SAN RAFFAELE SRL·Filed 2023·Application pending·0 cites
- 2358US12359217B2Virus vector productionOSPEDALE SAN RAFFAELE SRL·Filed 2019·Granted Jul 15, 2025·0 cites·18 claims
- 2458US11964027B2Method for improving retroviral transduction and gene editing in hematopoietic stem cells using cyclosporine h (CsH)OSPEDALE SAN RAFFAELE SRL·Filed 2018·Granted Apr 23, 2024·0 cites·17 claims
- 2557US2026000790A1Transgene cassettesOSPEDALE SAN RAFFAELE SRL·Filed 2023·Application pending·0 cites
- 2657US2023174622A1Epidermal growth factor receptorOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 2756US9561289B2Peptides for inhibiting tumor growthOSPEDALE SAN RAFFAELE SRL·Filed 2013·Granted Feb 7, 2017·0 cites·12 claims
- 2856US2018169184A1Inhibitor of IGFBP3/TMEM219 Axis and DiabetesOSPEDALE SAN RAFFAELE SRL·Filed 2016·Application pending·0 cites
- 2956US2025288617A1Gene TherapyOSPEDALE SAN RAFFAELE SRL·Filed 2023·Application pending·0 cites
- 3055US2020316168A1Inhibitors of igfbp3 binding to tmem219 for treatment of intestinal diseasesOSPEDALE SAN RAFFAELE SRL·Filed 2020·Application pending·0 cites
- 3155US2023340471A1Permanent Epigenetic Gene SilencingOSPEDALE SAN RAFFAELE SRL·Filed 2022·Application pending·0 cites
- 3254US2025215411A1Fusion proteins and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2023·Application pending·0 cites
- 3353US11597755B2TCR and peptidesOSPEDALE SAN RAFFAELE SRL·Filed 2018·Granted Mar 7, 2023·0 cites·41 claims
- 3452US2024000892A1Agents and Methods for Increasing Liver Immune ResponseOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 3552US2020237962A1Gene TherapyOSPEDALE SAN RAFFAELE SRL·Filed 2019·Application pending·0 cites
- 3652US2021290646A1Combination of a glycosylation inhibitor with one car cell therapy for treating cancerOSPEDALE SAN RAFFAELE SRL·Filed 2019·Application pending·0 cites
- 3752US2024425848A1Engineered transposase and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2022·Application pending·0 cites
- 3852US2023181719A1Ngr conjugates and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 3951US12059478B2Gene therapyOSPEDALE SAN RAFFAELE SRL·Filed 2017·Granted Aug 13, 2024·0 cites·28 claims
- 4051US9944899B2Tolerogenic dendritic cells, method for their production and uses therofOSPEDALE SAN RAFFAELE SRL·Filed 2015·Granted Apr 17, 2018·0 cites·19 claims
- 4151US2020338131A1MethodOSPEDALE SAN RAFFAELE SRL·Filed 2020·Application pending·0 cites
- 4251US2022098252A1Inhibitor of dux4 and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2020·Application pending·0 cites
- 4350US2025270546A1Guide rnas and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2022·Application pending·0 cites
- 4450US2022402980A1Chromogranin a-derived peptides and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2020·Application pending·0 cites
- 4550US2021317411A1Compositions and methods for haematopoietic stem cell transplantationOSPEDALE SAN RAFFAELE SRL·Filed 2019·Application pending·0 cites
- 4650US2025270306A1Antibodies and uses thereofOSPEDALE SAN RAFFAELE SRL·Filed 2025·Application pending·0 cites
- 4749US2024218330A1Compositions for improving the transduction of cells by viral vectorsOSPEDALE SAN RAFFAELE SRL·Filed 2022·Application pending·0 cites
- 4849US2025270587A1VectorOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 4948US12404284B2Spirocyclic inhibitors of hepatitis B virusOSPEDALE SAN RAFFAELE SRL·Filed 2021·Granted Sep 2, 2025·0 cites·17 claims
- 5048US10617721B2Methods for genetic modification of stem cellsOSPEDALE SAN RAFFAELE SRL·Filed 2014·Granted Apr 14, 2020·0 cites·23 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when OSPEDALE SAN RAFFAELE SRL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →